OSRH · OSR Health, Inc.
$0.12
-0.13 (-53.20%)
At close · Aug 25
View the 10-K filed Mar 31, 2026
Customer concentration
— top 3 customers 95% of revenue
3 customers — 95% of revenue (in recent years)
“Three main customers of RMC have in recent years represented approximately 95% of RMC's total sales.”
Market Cap
$8.78M
Shares
35.12M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.12
Open$0.22
Day$0.08–0.26
52W close$0.12–1.01
Avg vol 30d20.1M
Short int1.2M · 3.5% float · 1.4d
Short vol63%
DataMar 2023–Aug 2026
Filing10-Q · Aug 14
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.57
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−77%
below
Price vs 50-day avg
−69%
below
RSI (14)
33
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−74%
trailing
6-month return
−71%
trailing
YTD return
−79%
this year
Relative strength
−83%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+7% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.48% of float · ▲ +16.5% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
29 holders — mid 3-yr range
Squeeze score
45
elevated · 0–100
Fundamentals
Revenue growth
−18%
Y/Y
Gross margin
20%
contracting
EPS growth
+83%
Y/Y
Balance sheet
$813.0K
net debt
Quant / Vol
risk profile
Volatility
171%
annualized · 1-yr
Max drawdown
−88%
past year
ATR
89.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−77%
Bearish
Price vs 50-day avg
−69%
Bearish
RSI (14)
33
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+7% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
3.48% of float · ▲ +16.5% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
29 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $1
vs 200-day avg -77%
vs 50-day avg -69%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OSRH
this stock
OSR Health, Inc.
|
$8.78M | -79.3% | -17.7% | — | 3.5% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.79B | +21.9% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.30B | +8.0% | +20.8% | 20.5 | 2.3% |
|
ARGX
Argenx SE
|
$63.81B | +21.2% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$60.07B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OSRH | -72.8% | -74.4% | -71.4% | -73.9% | -79.3% |
| SPY | -0.2% | +3.4% | +11.8% | +2.5% | +12.3% |
| vs SPY | -72.6% | -77.8% | -83.2% | -76.4% | -91.6% |
Key facts
CIK
1840425
CUSIP
68840D102
13F (30d)
29 filings
29 filers
Visit website
Investor relations